• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Meta-Analysis Comparing Direct Oral Anticoagulants to Low Molecular Weight Heparin for Treatment of Venous Thromboembolism in Patients With Cancer.

作者信息

Bhatia Kirtipal, Uberoi Guneesh, Bajaj Navkaranbir S, Jain Vardhmaan, Arora Sameer, Tafur Alfonso, Bangalore Sripal, Olin Jeffrey W, Piazza Gregory, Goldhaber Samuel Z, Vaduganathan Muthiah, Qamar Arman

机构信息

Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York.

Division of Cardiology, University of Alabama School of Medicine, Birmingham, Alabama.

出版信息

Am J Cardiol. 2020 Oct 15;133:175-178. doi: 10.1016/j.amjcard.2020.07.027. Epub 2020 Jul 25.

DOI:10.1016/j.amjcard.2020.07.027
PMID:32807386
Abstract
摘要

相似文献

1
Meta-Analysis Comparing Direct Oral Anticoagulants to Low Molecular Weight Heparin for Treatment of Venous Thromboembolism in Patients With Cancer.比较直接口服抗凝剂与低分子肝素治疗癌症患者静脉血栓栓塞的Meta分析
Am J Cardiol. 2020 Oct 15;133:175-178. doi: 10.1016/j.amjcard.2020.07.027. Epub 2020 Jul 25.
2
Evaluation of direct oral anticoagulants for the treatment of cancer-associated thrombosis: an update.评估直接口服抗凝剂治疗癌症相关性血栓：更新。
J Thromb Thrombolysis. 2019 Apr;47(3):409-419. doi: 10.1007/s11239-018-1783-2.
3
Are direct oral anticoagulants an economically attractive alternative to low molecular weight heparins in lung cancer associated venous thromboembolism management?直接口服抗凝剂在肺癌相关静脉血栓栓塞症管理中作为低分子肝素的经济吸引力替代物？
J Thromb Thrombolysis. 2020 Oct;50(3):642-651. doi: 10.1007/s11239-020-02047-1.
4
Cancer is not a single disease: is it safe to extrapolate evidence from trials of direct oral anticoagulants in cancer-associated venous thromboembolism to patients with haematological malignancies?癌症并非单一疾病：将直接口服抗凝剂用于癌症相关静脉血栓栓塞症试验的证据外推至血液系统恶性肿瘤患者是否安全？
Br J Haematol. 2021 Apr;193(1):194-197. doi: 10.1111/bjh.17123. Epub 2021 Feb 22.
5
Direct oral anticoagulants and cancer-associated VTE: good for all, or just some?直接口服抗凝剂与癌症相关性静脉血栓栓塞症：适用于所有患者，还是仅适用于部分患者？
Blood. 2020 Aug 6;136(6):669-673. doi: 10.1182/blood.2019004177.
6
The treatment of cancer-associated venous thromboembolism in the era of the novel oral anticoagulants.新型口服抗凝剂时代癌症相关静脉血栓栓塞的治疗
Expert Opin Pharmacother. 2015;16(16):2391-4. doi: 10.1517/14656566.2015.1088003. Epub 2015 Sep 11.
7
Treatment of Venous Thromboembolism in Cancer. Historical Perspective and Evolving Role of the Direct Oral Anticoagulants.癌症患者静脉血栓栓塞的治疗。直接口服抗凝剂的历史回顾与作用演变
Cancer Treat Res. 2019;179:103-115. doi: 10.1007/978-3-030-20315-3_7.
8
Can I use direct oral anticoagulants to treat cancer-associated venous thromboembolism?我可以使用直接口服抗凝剂治疗癌症相关的静脉血栓栓塞症吗？
Cleve Clin J Med. 2020 Apr;87(4):201-203. doi: 10.3949/ccjm.87a.19100.
9
[Factor Xa inhibitors in the prevention and treatment of venous thromboembolism in cancer patients].[Xa因子抑制剂在癌症患者静脉血栓栓塞预防与治疗中的应用]
Tidsskr Nor Laegeforen. 2022 Dec 28;142(1). doi: 10.4045/tidsskr.22.0228. Print 2023 Jan 17.
10
Retrospective comparison of low molecular weight heparin vs. warfarin vs. oral Xa inhibitors for the prevention of recurrent venous thromboembolism in oncology patients: The Re-CLOT study.低分子量肝素与华法林及口服Xa因子抑制剂预防肿瘤患者复发性静脉血栓栓塞的回顾性比较：Re-CLOT研究
J Oncol Pharm Pract. 2018 Oct;24(7):494-500. doi: 10.1177/1078155217718382. Epub 2017 Jul 16.